Amid backlash, US FDA changes course over shortage of weight-loss drugs
23
votes
-
-
US FDA authorizes over-the-counter screening tests for COVID-19
6 votes -
US FDA reverses policy that let over 100 antibody tests on market without review
4 votes -
Experts voice concerns about Covid-19 testing accuracy
5 votes -
FDA requests removal of all ranitidine products (Zantac) from the market
7 votes -
US FDA turns to Twitter to help track testing supply shortages
4 votes -
FDA worried about blood shortage as donation drives are canceled amid coronavirus concerns
8 votes -
‘It’s just everywhere already’: How delays in testing set back the US coronavirus response
15 votes -
A spate of new class-action lawsuits threaten the CBD industry. Will they force Washington to act?
4 votes -
FDA approves ebola vaccine with 100% effectiveness
13 votes -
US FDA bowed to industry for decades as alarms were sounded over talc
7 votes -
The US health-care system found a way to make peanuts cost $4,200
8 votes -
The FDA is finalizing a plan to clear the market of all unauthorized flavored e-cigarette products to help combat youth usage
8 votes -
Ketamine: Now By Prescription
11 votes -
Despite warnings, US FDA approves potent new opioid painkiller
7 votes -
Psychedelic psilocybin therapy for depression granted breakthrough therapy status by FDA
11 votes -
No wonder it works so well: There may be Viagra in that herbal supplement
6 votes -
FDA cracks down on Juul and e-cigarette retailers
8 votes -
Does a generic EpiPen mean lower prices? Don’t hold your breath
8 votes -
FDA approves first generic version of EpiPen
18 votes -
A drug derived from marijuana has become the first to win Federal approval, and experts predict an avalanche effect
6 votes